Pulse Biosciences, Inc.
PLSEAs of the close on Sep 25, 2026
Price
$51.63
Market cap
—
The latest share count on file is too old
P/E (diluted TTM)
—
Per-share earnings are not available for each of the last four quarters
EPS (TTM)
—
Per-share earnings are not available for each of the last four quarters
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Pulse Biosciences, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 11 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 15, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| RHUMBLINE ADVISERS | 2026-03-31 | 22,902 | $494K | SEC filing |
| ROYAL BANK OF CANADA | 2026-03-31 | 1,079 | $23K | SEC filing |
| Stone House Investment Management, LLC | 2026-03-31 | 32 | $691 | SEC filing |
| NEW YORK STATE COMMON RETIREMENT FUND | 2026-03-31 | 4,652 | $100K | SEC filing |
| GOLDMAN SACHS GROUP INC | 2026-03-31 | 28,711 | $620K | SEC filing |
| Sterling Capital Management LLC | 2026-03-31 | 115 | $2.48K | SEC filing |
| Police & Firemen's Retirement System of New Jersey | 2026-03-31 | 4,643 | $100K | SEC filing |
| Cetera Investment Advisers | 2026-03-31 | 17,928 | $387K | SEC filing |
| ALLSTATE CORP | 2026-03-31 | 23,468 | $507K | SEC filing |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2026-03-31 | 14,859 | Not shown | SEC filing |
| Creative Planning | 2026-03-31 | 16,413 | $354K | SEC filing |
| Russell Investments Group, Ltd. | 2026-03-31 | 4,664 | $101K | SEC filing |
| Parkman Healthcare Partners LLC | 2026-03-31 | 50,125 | $1.08M | SEC filing |
| MILLENNIUM MANAGEMENT LLC | 2026-03-31 | 55,817 | $1.21M | SEC filing |
| Panoramic Capital, LLC | 2026-03-31 | 58,054 | $1.25M | SEC filing |
| WELLS FARGO & COMPANY/MN | 2026-03-31 | 9,195 | $199K | SEC filing |
| Swiss National Bank | 2026-03-31 | 39,100 | $844K | SEC filing |
| Fortitude Family Office, LLC | 2026-03-31 | 40 | $864 | SEC filing |
| ALLIANCEBERNSTEIN L.P. | 2026-03-31 | 12,900 | Not shown | SEC filing |
| GAMMA Investing LLC | 2026-03-31 | 316 | $6.82K | SEC filing |
- Each value is checked against Pulse Biosciences, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at Pulse Biosciences, Inc.'s share price.
- Value not shown for 1 row: the value per share could not be confirmed against the share prices on file from within three months of the report date.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- GRIFFIN ASSET MANAGEMENT, INC.: 226,312 shares reported 2025-12-31; 225,177 shares reported 2026-03-31.
- Allworth Financial LP: 17 shares reported 2025-12-31; 44 shares reported 2026-03-31.
- NORTHERN TRUST CORP: 184,251 shares reported 2025-12-31; 187,272 shares reported 2026-03-31.
- NATIONAL BANK OF CANADA /FI/: 500 shares reported 2025-12-31; 493 shares reported 2026-03-31.
- GEODE CAPITAL MANAGEMENT, LLC: 464,614 shares reported 2025-12-31; 491,946 shares reported 2026-03-31.
- DEUTSCHE BANK AG\: 21,516 shares reported 2025-12-31; 24,626 shares reported 2026-03-31.
- Aster Capital Management (DIFC) Ltd: 61 shares reported 2025-12-31; 105 shares reported 2026-03-31.
- Bank of New York Mellon Corp: 38,557 shares reported 2025-12-31; 38,477 shares reported 2026-03-31.
- Optiver Holding B.V.: 296 shares reported 2025-12-31; 160 shares reported 2026-03-31.
- UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC: 30,701 shares reported 2025-12-31; 31,820 shares reported 2026-03-31.
- Westside Investment Management, Inc.: 66,326 shares reported 2025-12-31; 70,492 shares reported 2026-03-31.
- UBS Group AG: 75,909 shares reported 2025-12-31; 33,954 shares reported 2026-03-31.
Showing the 12 most recent filer reports.
68 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Pulse Biosciences, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2024-12-11 · Barrett Burke Thomas: Larger than all 17 other insider sales of Common Stock on file. SEC filing
- 2024-07-03 · DUGGAN ROBERT W (derivative): Larger than 14 of the 15 other insider purchases of Warrant (right to buy) on file. SEC filing
- 2022-06-09 · DUGGAN ROBERT W (derivative): Larger than all 15 other insider purchases of Warrant (right to buy) on file. SEC filing
Independent insiders buying near the same time
- 2024-07-03–2024-07-03: 9 event(s) across 5 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing , filing , filing )
- 2023-11-15–2023-11-17: 16 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing )
- 2022-09-30–2022-10-07: 6 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing )
- 2022-06-09–2022-06-09: 7 event(s) across 4 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-05-11 (amended) | LAVIOLETTE PAUL A · Chief Executive Officer | Common Stock | P — Open market or private purchase | +15,000 | 19.69 | SEC filing |
| 2026-05-11 (amended) | DUGGAN ROBERT W · Director, 10% owner | Common Stock | P — Open market or private purchase | +660,233 | 19.69 | SEC filing |
| 2026-02-18 | Danahy Kevin Patrick · Chief Commercial Officer | Common Stock | S — Open market or private sale | −5,000 | 23.64 | SEC filing |
| 2026-02-17 | Danahy Kevin Patrick · Chief Commercial Officer | Common Stock | S — Open market or private sale | −20,000 | 23.63 | SEC filing |
| 2026-02-13 | Danahy Kevin Patrick · Chief Commercial Officer | Common Stock | S — Open market or private sale | −20,000 | 23.53 | SEC filing |
| 2026-02-12 | Danahy Kevin Patrick · Chief Commercial Officer | Common Stock | S — Open market or private sale | −20,000 | 23.37 | SEC filing |
| 2026-02-11 | Danahy Kevin Patrick · Chief Commercial Officer | Common Stock | S — Open market or private sale | −20,000 | 25.20 | SEC filing |
| 2026-02-10 | Danahy Kevin Patrick · Chief Commercial Officer | Common Stock | S — Open market or private sale | −20,000 | 23.52 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-11 | Sainz Maria · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +3,793 | SEC filing |
| 2026-06-11 | Zanganeh Mahkam · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +30,000 | SEC filing |
| 2026-06-11 | Soni Manmeet Singh · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +30,000 | SEC filing |
| 2026-06-11 | Sainz Maria · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +30,000 | SEC filing |
| 2026-06-11 | DUGGAN ROBERT W · Director, 10% owner | Stock Option (right to buy) | A — Grant, award, or other acquisition | +30,000 | SEC filing |
| 2026-06-11 | DUGGAN ROBERT W · Director, 10% owner | Stock Option (right to buy) | A — Grant, award, or other acquisition | +12,495 | SEC filing |
| 2026-06-11 | Zanganeh Mahkam · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +14,504 | SEC filing |
| 2026-06-11 | van den Broek Richard · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +30,000 | SEC filing |
Showing 8 of 20 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2023-11-01 | Danahy Kevin Patrick · Chief Executive Officer | Stock Option (right to buy) | J — Other acquisition or disposition | −130,000 | SEC filing |
Showing 1 of 1 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.